Financial supporters for this study had no role in study design, data collection, analysis, interpretation, writing, or publication of this work
What the research firmly supports: BPC-157's gut healing, vascular, and neuroprotective mechanisms (strong preclinical evidence) Thymosin Alpha-1's immune modulating and T-cell restorative effects (strong preclinical + clinical evidence in viral disease) TB-500's cardiovascular repair and angiogenic properties (strong preclinical, early human data) What the research does not yet confirm: Randomised controlled trial data specifically in long COVID populations Optimal dosing, sequencing, and duration specifically for PASC Long-term safety data for extended post-viral use This doesn't mean these peptides don't work for long COVID
60% of GLP-1 users are willing to spend more for quality or brand-name clothing
However, it is important to note that analyzing clinical differences using spontaneous reporting system databases presents inherent challenges due to confounding factors
Community & Tools: The Ivm Health app helps you track progress and stay connected, while community support connects you with others on similar journeys
& Goldring, M
